Showing of 5 results
Fabio Cominelli, MD discusses how his team of researchers discovered the specific blockade of interleukin-18 can reduce disease severity in colitis and new personalized therapies to put IBD in permanent remission.
Treatment moves toward less use of antibiotics, less emphasis on surgery - Innovations in Digestive Health | Winter 2021
Digestive Diseases Research Core Center receives additional grant; screenings rise during pandemic | Innovations in Digestive Health | Fall 2020
$6M, 5-year NIH grant extends funding for collaborative Cleveland Digestive Diseases Research Core Center
CWRU News Release
Gut instincts - Innovations in Digestive Health | Winter 2020